Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in Recurrent Anaplastic Oligodendroglioma or Oligoastrocytoma
NCT00003372Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 1997
- Primary completion
- Oct 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in anaplastic oligodendroglioma (AO), anaplastic oligoastrocytoma (AOA), sponsored by Canadian Cancer Trials Group. Started Dec 1997; status: completed.
02
Drugs
topotecan
03
Conditions
anaplastic oligodendroglioma (AO)anaplastic oligoastrocytoma (AOA)
Beyond the preview
Go deeper on NCT00003372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003372.